NASDAQ:CLPT

ClearPoint Neuro (CLPT) Stock Price, News & Analysis

ClearPoint Neuro logo
$7.31 -0.40 (-5.19%)
Closing price 04:00 PM Eastern
Extended Trading
$7.32 +0.01 (+0.07%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About ClearPoint Neuro Stock (NASDAQ:CLPT)

Advanced

Key Stats

Today's Range
$7.25
▼
$7.95
50-Day Range
$7.31
▼
$15.79
52-Week Range
$7.25
▼
$19.63
Volume
704,764 shs
Average Volume
714,779 shs
Market Capitalization
$234.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.33
Consensus Rating
Hold

Company Overview

ClearPoint Neuro develops technologies used to plan, guide and monitor minimally invasive procedures in the brain and spine. Its product portfolio includes MRI-guided navigation systems and instruments for neurosurgery, including tools for laser ablation and for delivering therapeutics to targeted areas of the central nervous system.

The company also works with biotechnology and pharmaceutical partners on the delivery of cell and gene therapies and other biologics to the brain. Its platforms are designed to support accurate placement and monitoring during procedures and in clinical research.

ClearPoint Neuro was formerly known as MRI Interventions and adopted its current name in 2020. The company serves hospitals, research institutions and industry partners in the United States and internationally.

AI Generated. May Contain Errors.

ClearPoint Neuro Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

CLPT MarketRank™: 
1.98027937551 of 5 stars

ClearPoint Neuro scored higher than 40% of companies evaluated by MarketBeat, and ranked 630th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ClearPoint Neuro has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    ClearPoint Neuro has a consensus price target of $24.33, representing about 232.9% upside from its current price of $7.31.

  • Amount of Analyst Coverage

    ClearPoint Neuro has only been the subject of 2 research reports in the past 90 days.

  • Read more about ClearPoint Neuro's stock forecast and price target.
  • Earnings Growth

    Earnings for ClearPoint Neuro are expected to grow in the coming year, from ($1.17) to ($0.97) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ClearPoint Neuro is -6.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ClearPoint Neuro is -6.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ClearPoint Neuro has a P/B Ratio of 8.60. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    14.40% of the float of ClearPoint Neuro has been sold short.
  • Short Interest Ratio / Days to Cover

    ClearPoint Neuro has a short interest ratio ("days to cover") of 6.56.
  • Change versus previous month

    Short interest in ClearPoint Neuro has recently decreased by 7.23%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    ClearPoint Neuro does not currently pay a dividend.

  • Dividend Growth

    ClearPoint Neuro does not have a long track record of dividend growth.

  • Search Interest

    2 people have searched for CLPT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ClearPoint Neuro insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    6.94% of the stock of ClearPoint Neuro is held by insiders.

  • Percentage Held by Institutions

    30.08% of the stock of ClearPoint Neuro is held by institutions.

  • Read more about ClearPoint Neuro's insider trading history.
Receive CLPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLPT Stock News Headlines

ClearPoint Neuro (CLPT) AI Stock Analysis
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
ClearPoint Neuro: Momentum Building Across The Business
See More Headlines

CLPT Stock Analysis - Frequently Asked Questions

ClearPoint Neuro's stock was trading at $13.68 at the beginning of 2026. Since then, CLPT stock has decreased by 46.6% and is now trading at $7.31.

ClearPoint Neuro, Inc. (NASDAQ:CLPT) posted its quarterly earnings data on Wednesday, October, 28th. The company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates of ($0.32) by $0.08. The firm earned $12.08 million during the quarter, compared to analyst estimates of $12.30 million. ClearPoint Neuro had a negative trailing twelve-month return on equity of 170.24% and a negative net margin of 79.43%.
Read the conference call transcript
.

ClearPoint Neuro's top institutional investors include State Street Corp (2.73%), Marshall Wace LLP (1.66%), Goldman Sachs Group Inc. (1.09%) and Pekin Hardy Strauss Inc. (0.87%). Insiders that own company stock include Joseph Burnett, Timothy T Richards, Lynnette C Fallon and Matthew B Klein.
View institutional ownership trends
.

Shares of CLPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ClearPoint Neuro investors own include Palantir Technologies (PLTR), Block (XYZ), NVIDIA (NVDA), TransMedics Group (TMDX), Trade Desk (TTD), Stem (STEM) and Super Micro Computer (SMCI).

Company Calendar

Last Earnings
10/28/2026
Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:CLPT
CIK
1285550
Employees
172
Year Founded
1998

Price Target and Rating

High Price Target
$30.00
Low Price Target
$18.00
Potential Upside/Downside
+232.9%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$25.54 million
Net Margins
-79.43%
Pretax Margin
-79.50%
Return on Equity
-170.24%
Return on Assets
-37.00%

Debt

Debt-to-Equity Ratio
1.86
Current Ratio
6.76
Quick Ratio
5.77

Sales & Book Value

Annual Sales
$36.97 million
Price / Sales
6.34
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.85 per share
Price / Book
8.60

Miscellaneous

Outstanding Shares
32,050,000
Free Float
29,829,000
Market Cap
$234.29 million
Optionable
Optionable
Beta
1.38

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:CLPT) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners